Adrenergic nerve fibers are depleted in adenomyosis myometrium

Observational preprint OA: green CC-BY-NC-4.0
⚙ AI-generated summary by qwen3.7-flash, 2026-11-18 ⓘ

Adenomyosis uteri exhibit four-fold lower adrenergic nerve fiber density in the inner myometrium compared to controls, potentially explaining junctional zone thickening and dyscontractility through altered neuro-muscular contraction mechanisms.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-11-18 · read from full text ⓘ

This retrospective study compared full-thickness myometrial biopsies from patients undergoing hysterectomy for adenomyosis against controls with non-adenomyosis indications to investigate the cellular basis of uterine dyscontractility. Using immunofluorescence and machine-learning segmentation, researchers analyzed density profiles of smooth muscle, endothelium, collagen, and nerve fibers across the serosa-to-endometrium axis. The key finding was that adrenergic inhibitory nerve fibers were significantly less dense in the inner myometrium of adenomyosis patients compared to controls, while other tissue components remained similar. This depletion suggests a mechanism where a thicker myometrial layer participates in contractions, leading to junctional zone thickening and pain. Relevance to endometriosis: listed as one indication for GnRH antagonists, though the paper's main focus is uterine fibroids.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Objective: Uterine dyscontractility in adenomyosis and endometriosis is at the heart of pain symptoms and disease pathogenesis. To elucidate possible causes of dyscontractility, we examined the distribution of smooth muscle, blood vessel, collagen and nerve fibers in full-thickness, serosa-to-endometrium myometrium of adenomyosis patients versus control. Design: Retrospective study. Subjects: Uterine biopsies from patients who underwent hysterectomy for adenomyosis (n = 26) or other non-adenomyosis indications (n=22, mostly myomas). Main Outcome Measures: Density profiles along the serosa-to-endometrium axis of smooth muscle (αSMA), endothelium (PECAM), general innervation (PGP9.5) and adrenergic innervation (TH) obtained by immunofluorescence, mosaic epifluorescence imaging and machine-learning assisted segmentation. Fibrous collagen type I&III was quantified by second-harmonic generation microscopy (SHG). Results: The density profiles of smooth muscle, endothelium, collagen and PGP9.5 were similar between both patient groups. Sympathetic adrenergic nerve fiber density radiated from the serosa inwards, with a continuously decreasing density from the outer to the inner myometrium. Adrenergic inhibitory nerve fibers were 4 times less dense in the inner myometrium of adenomyosis uteri compared to controls. Conclusion: The enrichment of inhibitory adrenergic nerve fibers in the outer vs inner myometrium provides a neuro-muscular mechanism by which contractions are restricted to the inner myometrium outside of pregnancy. The depletion of TH fibers in adenomyosis implies that a higher thickness of myometrium is involved in uterine contractions, thus explaining junctional zone thickening and dyscontractility in this pathology. This depletion may be due to defective post-pregnancy adrenergic re-innervation of the myometrium.
Full text 3,670 characters · extracted from oa-html · click to expand
Abstract Objective: Uterine dyscontractility in adenomyosis and endometriosis is at the heart of pain symptoms and disease pathogenesis. To elucidate possible causes of dyscontractility, we examined the distribution of smooth muscle, blood vessel, collagen and nerve fibers in full-thickness, serosa-to-endometrium myometrium of adenomyosis patients versus control. Design: Retrospective study. Subjects: Uterine biopsies from patients who underwent hysterectomy for adenomyosis (n = 26) or other non-adenomyosis indications (n=22, mostly myomas). Main Outcome Measures: Density profiles along the serosa-to-endometrium axis of smooth muscle (αSMA), endothelium (PECAM), general innervation (PGP9.5) and adrenergic innervation (TH) obtained by immunofluorescence, mosaic epifluorescence imaging and machine-learning assisted segmentation. Fibrous collagen type I&III was quantified by second-harmonic generation microscopy (SHG). Results: The density profiles of smooth muscle, endothelium, collagen and PGP9.5 were similar between both patient groups. Sympathetic adrenergic nerve fiber density radiated from the serosa inwards, with a continuously decreasing density from the outer to the inner myometrium. Adrenergic inhibitory nerve fibers were 4 times less dense in the inner myometrium of adenomyosis uteri compared to controls. Conclusion: The enrichment of inhibitory adrenergic nerve fibers in the outer vs inner myometrium provides a neuro-muscular mechanism by which contractions are restricted to the inner myometrium outside of pregnancy. The depletion of TH fibers in adenomyosis implies that a higher thickness of myometrium is involved in uterine contractions, thus explaining junctional zone thickening and dyscontractility in this pathology. This depletion may be due to defective post-pregnancy adrenergic re-innervation of the myometrium. Competing Interest Statement The authors have declared no competing interest. Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: Approval for this study was granted on the 27th of January 2025 under IRB number 00012157 from the Groupe Ethique Recherche Medicale (GERM) of Hopital Paris Saint Joseph. The first patient was included on the 26th of February 2025. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data Availability Essential data generated or analyzed during this study are included in this report and its supplementary information files. Further data are available from the corresponding author upon reasonable request.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-html ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-11-18T06:41:32.248459+00:00
openalex
last seen: 2026-11-18T06:02:33.299327+00:00
unpaywall
last seen: 2026-11-18T06:44:38.916964+00:00
License: CC-BY-NC-4.0